Login / Signup

Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques.

Anandani NellanCynthia M Lester McCullyRafael Cruz GarciaNalini JayaprakashBrigitte C WidemannDaniel W LeeKatherine E Warren
Published in: Blood (2018)
Keyphrases
  • cerebrospinal fluid
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • high dose
  • blood brain barrier
  • rheumatoid arthritis patients
  • disease activity
  • low dose
  • systemic lupus erythematosus